ORMALVI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ormalvi, and what generic alternatives are available?
Ormalvi is a drug marketed by Torrent and is included in one NDA.
The generic ingredient in ORMALVI is dichlorphenamide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORMALVI?
- What are the global sales for ORMALVI?
- What is Average Wholesale Price for ORMALVI?
Summary for ORMALVI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| DailyMed Link: | ORMALVI at DailyMed |
Pharmacology for ORMALVI
| Drug Class | Carbonic Anhydrase Inhibitor |
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
US Patents and Regulatory Information for ORMALVI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torrent | ORMALVI | dichlorphenamide | TABLET;ORAL | 215924-001 | Dec 29, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
